GB1577825A - Intraocular lens - Google Patents

Intraocular lens Download PDF

Info

Publication number
GB1577825A
GB1577825A GB16140/78A GB1614078A GB1577825A GB 1577825 A GB1577825 A GB 1577825A GB 16140/78 A GB16140/78 A GB 16140/78A GB 1614078 A GB1614078 A GB 1614078A GB 1577825 A GB1577825 A GB 1577825A
Authority
GB
United Kingdom
Prior art keywords
wire
cladding
platinum
titanium
noble metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB16140/78A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Optical Corp
Original Assignee
American Optical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Optical Corp filed Critical American Optical Corp
Publication of GB1577825A publication Critical patent/GB1577825A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2002/1681Intraocular lenses having supporting structure for lens, e.g. haptics
    • A61F2002/1683Intraocular lenses having supporting structure for lens, e.g. haptics having filiform haptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Description

(54) INTRAOCULAR LENS (71) We, AMERICAN OPTICAL COR PORATION, a corporation organized under the laws of the State of Delaware, United States of America, of 14 Mechanic Street, Southbridge, Massachusetts, United States of America, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: This invention is concerned with intraocular lenses, more particularly such lenses having wire secured thereto for fixing the lenses in place.
In the manufacture of wire, a lubricant is usually used to prevent sticking and galling in the dies and it is customary to use a relatively soft metal cladding as the lubricant in cases where liquid lubricants are known to be unreliable. Such is the case with titanium wire which, because of its low density and biocompatability, is ideally suited for fixing artificial intraocular lenses (pseudophakoi) in place. The use of liquid or chemical lubricants does not overcome the tendency for titanium to stick and gall in drawing dies.
Claddings used heretofore to lubricate titanium have been base metals such as nickel and copper which require complete removal from the finished wire before use in the body. Not being biocompatible and accordingly potentially toxic or infective, the nickel or copper claddings are stripped with acid which involves tedious, time consuming and costly operations requiring careful monitoring for assurance of complete removal of the base metal.
We have now found that noble metals are effective lubricants for use in the drawing of titanium wire and are biocompatible so that claddings of them to not have to be removed from the finished wire before intraocular use.
According to the present invention, therefore, there is provided an intraocular lens having wire secured thereto for fixing the lens, in place, the wire consisting of a core of titanium having a noble metal cladding thereon.
The wire is preferably made by tightly fitting a tube of noble metal upon a titanium rod and drawing the resulting composite into wire.
The thickness of the noble metal cladding is preferably kept as low as possible, that is the cladding preferably forms not more than 5% of the cross-sectional area of the wire, so that the advantage of the low density of titanium is not appreciably adversely affected by the added cladding.
In the following description, reference will be made to the accompanying drawings, in which: Figure 1 is an illustration of an exemplary artificial intraocular lens (pseudophakos) in accordance with the invention, and Figure 2 is a greatly enlarged crosssectional view taken on line 2-2 of Figure 1.
Figure 1 of the drawings illustrates a typical pseudophakos 10 comprised of a lens 12 having loops of wire 14 secured thereto for use in fixing the pseudophakos in place within the eye of an aphakic.
For the purpose of minimizing the weight of the pseudophakos 10, the lens 12 is preferably formed of a lightweight polymer, such as polymethyl methacrylate, and wires 14 are formed of a durable shape-retaining lightweight material. This material, according to the present invention, is titanium, which is noted for its exceptionally low density, having a noble metal cladding.
While pseudophakos 10 is of the type traditionally used for iridocapsular implantation, it should be understood that it has been selected only for purposes of illustrating the applicability of the present invention to intraocular use. The illustration is not intended to restrict the invention to any particular type or construction of pseudophakos and/or other prosthesis. Those interested in further details of intraocular prostheses may refer to U.S. Patents Nos.
3,971,073; 3,996,626; 4,012,823; and 4,014,049; there being various other types and forms of prosthetic device which may benefit from the present invention.
According to the invention the traditional base metal cladding of nickel or copper which has been used to lubricate titanium for drawing into wire is replaced by a thin cladding of a noble metal or noble metal alloy which is biologically inert, i.e. noninfective and non-receptable when implanted under the traditional sterile conditions of surgery.
The cladding and wire drawing operation may be performed with conventional apparatus and/or procedure well known to those skilled in the art and requiring no description herein. Those interested in details of suitable wire drawing systems may refer to Metals Handbook, (1948), pages 357 to 360; 1101 and 1102.
Referring more particularly to Figure 2, it can be seen that wire 14 comprises a core or main body 16 of titanium having cladding 18 which, in a preferred form of the invention, occupies less than 5% of the cross- sectional area of the wire 14. Thus, the weight of the cladding 18 is negligible and the advantage of low density afforded by the titanium 16 is substantially unaffected by the cladding 18.
In a preferred embodiment of the wire 14, the cladding 18 consists of pure platinum or a platinum alloy, such as 90% platinum and 10% iridium, or pure gold or any of the number of noble metals known to metallurgists as being in the platinum or gold families and/or alloys thereof.
Wire 14 is suitably made by providing a titanium rod of approximately 6 mm to 13 mm diameter with a tight fitting tube of platinum or platinum alloy or other noble metal of such wall thickness that approximately 5% of the cross-sectional area of the composite comprises the tube. The assembly is then rolled to a reduced diameter of approximately 3 mm and drawn in the normal manner to a size of from 0.025 mm to 0.25 mm diameter. A wire size conventionally used in pseudophakoi is 0.127 mm diameter.
The wire thus formed may then be cut to length, shaped by bending and secured to the lens of the pseudophakos without further processing, i.e. without stripping of the cladding. The noble metal cladding having performed its function as a soft metal lubricant permitting drawing of the titanium without sticking or galling is allowed to remain intact. It is biocompatible and its contribution to the weight of the titanium wire is negligible.
WHAT WE CLAIM IS:- 1. An intraocular lens having wire secured thereto for fixing the lens in place, the wire consisting of a core of titanium having a noble metal cladding thereon.
2. A lens according to claim 1, in which the cladding forms not more than 5% of the cross sectional area of the wire.
3. A lens according to claim 1 or 2, in which the noble metal is platinum or a platinum alloy.
4. A lens according to claim 3, in which the platinum alloy is an alloy of approximately 90% platinum and approximately 10% iridium.
5. A lens according to claim 1 or 2, in which the noble metal is gold.
6. A lens according to any of claims 1 to 5, in which the wire is made by tightly fitting a tube of the noble metal upon a titanium rod and drawing the resulting composite into wire.
7. A lens according to claim 6, in which the composite is rolled to a reduced crosssectional area prior to drawing.
8. A lens according to claim 6 or 7, in which the wire is drawn to a diameter of 0.025 to 0.25 mm.
9. A lens according to claim 1, substantially as described herein with reference to the accompanying drawings.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (9)

**WARNING** start of CLMS field may overlap end of DESC **. 4,014,049; there being various other types and forms of prosthetic device which may benefit from the present invention. According to the invention the traditional base metal cladding of nickel or copper which has been used to lubricate titanium for drawing into wire is replaced by a thin cladding of a noble metal or noble metal alloy which is biologically inert, i.e. noninfective and non-receptable when implanted under the traditional sterile conditions of surgery. The cladding and wire drawing operation may be performed with conventional apparatus and/or procedure well known to those skilled in the art and requiring no description herein. Those interested in details of suitable wire drawing systems may refer to Metals Handbook, (1948), pages 357 to 360; 1101 and 1102. Referring more particularly to Figure 2, it can be seen that wire 14 comprises a core or main body 16 of titanium having cladding 18 which, in a preferred form of the invention, occupies less than 5% of the cross- sectional area of the wire 14. Thus, the weight of the cladding 18 is negligible and the advantage of low density afforded by the titanium 16 is substantially unaffected by the cladding 18. In a preferred embodiment of the wire 14, the cladding 18 consists of pure platinum or a platinum alloy, such as 90% platinum and 10% iridium, or pure gold or any of the number of noble metals known to metallurgists as being in the platinum or gold families and/or alloys thereof. Wire 14 is suitably made by providing a titanium rod of approximately 6 mm to 13 mm diameter with a tight fitting tube of platinum or platinum alloy or other noble metal of such wall thickness that approximately 5% of the cross-sectional area of the composite comprises the tube. The assembly is then rolled to a reduced diameter of approximately 3 mm and drawn in the normal manner to a size of from 0.025 mm to 0.25 mm diameter. A wire size conventionally used in pseudophakoi is 0.127 mm diameter. The wire thus formed may then be cut to length, shaped by bending and secured to the lens of the pseudophakos without further processing, i.e. without stripping of the cladding. The noble metal cladding having performed its function as a soft metal lubricant permitting drawing of the titanium without sticking or galling is allowed to remain intact. It is biocompatible and its contribution to the weight of the titanium wire is negligible. WHAT WE CLAIM IS:-
1. An intraocular lens having wire secured thereto for fixing the lens in place, the wire consisting of a core of titanium having a noble metal cladding thereon.
2. A lens according to claim 1, in which the cladding forms not more than 5% of the cross sectional area of the wire.
3. A lens according to claim 1 or 2, in which the noble metal is platinum or a platinum alloy.
4. A lens according to claim 3, in which the platinum alloy is an alloy of approximately 90% platinum and approximately 10% iridium.
5. A lens according to claim 1 or 2, in which the noble metal is gold.
6. A lens according to any of claims 1 to 5, in which the wire is made by tightly fitting a tube of the noble metal upon a titanium rod and drawing the resulting composite into wire.
7. A lens according to claim 6, in which the composite is rolled to a reduced crosssectional area prior to drawing.
8. A lens according to claim 6 or 7, in which the wire is drawn to a diameter of 0.025 to 0.25 mm.
9. A lens according to claim 1, substantially as described herein with reference to the accompanying drawings.
GB16140/78A 1977-05-02 1978-04-24 Intraocular lens Expired GB1577825A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79321577A 1977-05-02 1977-05-02

Publications (1)

Publication Number Publication Date
GB1577825A true GB1577825A (en) 1980-10-29

Family

ID=25159403

Family Applications (1)

Application Number Title Priority Date Filing Date
GB16140/78A Expired GB1577825A (en) 1977-05-02 1978-04-24 Intraocular lens

Country Status (2)

Country Link
AU (1) AU3538278A (en)
GB (1) GB1577825A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612012A (en) * 1982-07-28 1986-09-16 White Thomas C Corneal implant
EP0567627A1 (en) * 1991-11-14 1993-11-03 POLER, Stanley Secondary eye growth impeding device and method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612012A (en) * 1982-07-28 1986-09-16 White Thomas C Corneal implant
EP0567627A1 (en) * 1991-11-14 1993-11-03 POLER, Stanley Secondary eye growth impeding device and method
EP0567627A4 (en) * 1991-11-14 1994-06-22 Stanley Poler Secondary eye growth impeding device and method

Also Published As

Publication number Publication date
AU3538278A (en) 1979-11-01

Similar Documents

Publication Publication Date Title
US6248190B1 (en) Process of making composite stents with gold alloy cores
JP2746755B2 (en) Clad composite stent
US6527802B1 (en) Clad composite stent
CA2188429C (en) Clad composite stent
US20110160842A1 (en) Clad Composite Stent
DE2723518A1 (en) HOLDER FOR A LENS INSERTIBLE IN THE HUMAN EYE AND METHOD OF MANUFACTURING IT
CA2351326A1 (en) Optical fiber connector and ferrule used for it and production method for ferrule
US4472035A (en) Eyeglass-frame
US4387492A (en) Plated jacket soft point bullet
DE69926496T2 (en) INTRAOCULAR LENSES WHICH ALLOW THE DETERMINATION OF THE AXIAL SHIFT AFTER IMPLANTATION
GB1567507A (en) Intraocular lenses and method of making the same
US4351326A (en) Copper wire for intrauterina contraceptive devices and a method for manufacturing the same
US20070073374A1 (en) Endoprostheses including nickel-titanium alloys
GB1577825A (en) Intraocular lens
EP0251436A3 (en) High pressure sodium discharge lamps with hydrogen getter
JP2812860B2 (en) Intraocular lens
US4012823A (en) Method of making artificial intraocular lenses
DE102007057122A1 (en) Intraocular lens for implantation in eye, particularly human eye, has lens, which has optical axis, anterior optical surface that is transverse to optical axis, and posterior optical surface that is opposite to anterior optical surface
US4139915A (en) Artificial intraocular lens
GB845241A (en) Improvements in or relating to waveguides and methods of bending waveguides
US387774A (en) Artificial tooth-crown
DD126402B1 (en) Implantable eye lens
Lunarska et al. Fatigue Structure of Burnished WT-3-1 Titanium Alloy
MX9605485A (en) Clad composite stent.
DE2740330A1 (en) Filament mounting in miniature lamps - secures filament sections with core wires to electrodes, followed by core wire dissolution in acid bath

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed